Compare Stocks: LFWD, NRXS, OM, and DXR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DXR Daxor	$10.55 -1.8%	$10.39	$8.56 ▼ $14.76	$62.70M	0.26	4,942 shs	51,551 shs
LFWD Lifeward	$7.10 -2.2%	$7.54	$4.14 ▼ $10.56	$20.56M	0.39	6,496 shs	4,242 shs
NRXS NeurAxis	$6.07 +2.0%	$6.63	$2.21 ▼ $9.33	$76.23M	1.47	130,950 shs	69,740 shs
OM Outset Medical	$3.57 -2.7%	$4.44	$3.00 ▼ $16.16	$68.99M	1.9	145,364 shs	91,816 shs

10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DXR Daxor	-3.48%	+3.97%	-2.24%	-4.18%	-0.04%
LFWD Lifeward	+0.83%	-3.07%	+0.97%	+1.26%	-2.01%
NRXS NeurAxis	+2.41%	-0.17%	-9.71%	-18.16%	+126.24%
OM Outset Medical	+0.82%	-13.65%	-26.45%	-22.41%	-73.29%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
DXR Daxor	$10.55 -1.8%	$10.39	$8.56 ▼ $14.76	$62.70M	0.26	4,942 shs	51,551 shs
LFWD Lifeward	$7.10 -2.2%	$7.54	$4.14 ▼ $10.56	$20.56M	0.39	6,496 shs	4,242 shs
NRXS NeurAxis	$6.07 +2.0%	$6.63	$2.21 ▼ $9.33	$76.23M	1.47	130,950 shs	69,740 shs
OM Outset Medical	$3.57 -2.7%	$4.44	$3.00 ▼ $16.16	$68.99M	1.9	145,364 shs	91,816 shs

10 Best Stocks to Own - Summer 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
DXR Daxor	-3.48%	+3.97%	-2.24%	-4.18%	-0.04%
LFWD Lifeward	+0.83%	-3.07%	+0.97%	+1.26%	-2.01%
NRXS NeurAxis	+2.41%	-0.17%	-9.71%	-18.16%	+126.24%
OM Outset Medical	+0.82%	-13.65%	-26.45%	-22.41%	-73.29%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
DXR Daxor	2.50	Moderate Buy	N/A	N/A
LFWD Lifeward	2.25	Hold	$10.00	40.85% Upside
NRXS NeurAxis	3.00	Buy	$13.00	114.17% Upside
OM Outset Medical	2.40	Hold	$10.00	180.11% Upside

Current Analyst Ratings Breakdown

Latest LFWD, NRXS, OM, and DXR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/2/2026	LFWD Lifeward	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/21/2026	OM Outset Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/21/2026	LFWD Lifeward	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/21/2026	LFWD Lifeward	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$10.00
8/18/2026	LFWD Lifeward	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/7/2026	OM Outset Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/3/2026	LFWD Lifeward	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/27/2026	LFWD Lifeward	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
7/17/2026	LFWD Lifeward	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/24/2026	DXR Daxor	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
6/24/2026	OM Outset Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 9/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
DXR Daxor	N/A	N/A	N/A	N/A	N/A	N/A
LFWD Lifeward	$22.03M	0.91	N/A	N/A	$4.31 per share	1.65
NRXS NeurAxis	$5.32M	14.34	N/A	N/A	($0.27) per share	-22.48
OM Outset Medical	$119.48M	0.56	N/A	N/A	$5.13 per share	0.70

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
DXR Daxor	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LFWD Lifeward	-$19.91M	-$16.82	N/A	N/A	N/A	-141.28%	-235.86%	-81.72%	11/13/2026 (Estimated)
NRXS NeurAxis	-$14.63M	-$0.78	N/A	N/A	N/A	-492.76%	N/A	-641.25%	11/17/2026 (Estimated)
OM Outset Medical	-$81.65M	-$4.09	N/A	N/A	N/A	-63.06%	-61.67%	-28.25%	11/9/2026 (Estimated)

Latest LFWD, NRXS, OM, and DXR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/15/2026	Q2 2026	LFWD Lifeward	-$1.39	-$1.46	-$0.07	-$4.12	$6.53 million	$6.62 million
8/6/2026	Q2 2026	OM Outset Medical	-$0.7167	-$0.80	-$0.0833	-$0.97	$28.97 million	$31.64 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
DXR Daxor	N/A	N/A	N/A	N/A	N/A
LFWD Lifeward	N/A	N/A	N/A	N/A	N/A
NRXS NeurAxis	N/A	N/A	N/A	N/A	N/A
OM Outset Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
DXR Daxor	N/A	N/A	N/A
LFWD Lifeward	0.70	2.33	1.77
NRXS NeurAxis	N/A	0.24	0.23
OM Outset Medical	1.03	5.19	4.11

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
DXR Daxor	1.34%
LFWD Lifeward	26.76%
NRXS NeurAxis	11.77%
OM Outset Medical	N/A

Insider Ownership

Company	Insider Ownership
DXR Daxor	51.50%
LFWD Lifeward	1.50%
NRXS NeurAxis	21.10%
OM Outset Medical	2.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
DXR Daxor	37	5.84 million	2.83 million	Not Optionable
LFWD Lifeward	60	2.83 million	2.79 million	Optionable
NRXS NeurAxis	19	12.56 million	6.09 million	Not Optionable
OM Outset Medical	520	18.80 million	18.33 million	Not Optionable

LFWD, NRXS, OM, and DXR Headlines

Recent News About These Companies

Outset Medical Announces Departure of General Counsel Brottem

August 28, 2026 | tipranks.com

Outset Medical (NASDAQ:OM) General Counsel John Brottem Sells 2,632 Shares

August 19, 2026 | insidertrades.com

Leslie Trigg Sells 3,437 Shares of Outset Medical (NASDAQ:OM) Stock

August 18, 2026 | marketbeat.com

Outset Medical Earnings Call Highlights Refresh Tailwinds

August 18, 2026 | tipranks.com

Insider Selling: Outset Medical (NASDAQ:OM) General Counsel Sells $11,554.48 in Stock

August 18, 2026 | marketbeat.com

Outset Medical (NASDAQ:OM) CFO Renee Gaeta Sells 4,543 Shares of Stock

August 18, 2026 | marketbeat.com

Despite Fast-paced Momentum, Outset Medical (OM) Is Still a Bargain Stock

August 18, 2026 | zacks.com

Outset Medical (NASDAQ:OM) Raised to Hold at Wall Street Zen

August 15, 2026 | marketbeat.com

Outset Medical (OM) Q2 2026 Earnings Call Transcript

August 14, 2026 | finance.yahoo.com

Outset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of "Hold" by Analysts

August 13, 2026 | marketbeat.com

Stifel Nicolaus Keeps Their Buy Rating on Outset Medical (OM)

August 11, 2026 | theglobeandmail.com

Outset Medical (NASDAQ:OM) Issues Quarterly Earnings Results

August 7, 2026 | marketbeat.com

Outset Medical, Inc. (OM) Q2 2026 Earnings Call Transcript

August 7, 2026 | seekingalpha.com

Outset Medical Q2 Earnings Call Highlights

August 7, 2026 | marketbeat.com

Outset Medical rapporteert gemengde Q2 2026-resultaten, aandeel licht hoger

August 6, 2026 | nl.investing.com

Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates

August 6, 2026 | zacks.com

Outset Medical (OM) Stock Falls on Q2 2026 Earnings

August 6, 2026 | quiverquant.comQ

Outset Medical Reports Second Quarter 2026 Results

August 6, 2026 | markets.businessinsider.com

Der aktuelle Kurs der Outset Medical Inc Aktie beträgt 5,060.

August 5, 2026 | de.investing.com

Did Outset Medical, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

July 29, 2026 | prnewswire.com

Outset Medical to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

July 23, 2026 | markets.businessinsider.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

LFWD, NRXS, OM, and DXR Company Descriptions

Daxor NASDAQ:DXR

$10.55 -0.19 (-1.77%)

As of 03:49 PM Eastern

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

Lifeward NASDAQ:LFWD

$7.10 -0.16 (-2.20%)

As of 04:00 PM Eastern

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

NeurAxis NASDAQ:NRXS

$6.07 +0.12 (+2.02%)

As of 04:00 PM Eastern

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Outset Medical NASDAQ:OM

$3.57 -0.10 (-2.72%)

As of 04:00 PM Eastern

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LFWD, NRXS, OM, and DXR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LFWD, NRXS, OM, and DXR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LFWD, NRXS, OM, and DXR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

LFWD, NRXS, OM, and DXR Company Descriptions

Daxor NASDAQ:DXR

Lifeward NASDAQ:LFWD

NeurAxis NASDAQ:NRXS

Outset Medical NASDAQ:OM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LFWD, NRXS, OM, and DXR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LFWD, NRXS, OM, and DXR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LFWD, NRXS, OM, and DXR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

LFWD, NRXS, OM, and DXR Company Descriptions

Daxor NASDAQ:DXR

Lifeward NASDAQ:LFWD

NeurAxis NASDAQ:NRXS

Outset Medical NASDAQ:OM

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools